Market Overview:
The global bacterial and viral antigens market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for advanced diagnostic tests, and rising funding for research on infectious diseases. The bacterial and viral antigens market is segmented by type into inactivated pathogens and purified pathogens. The purified pathogens segment is expected to grow at a higher CAGR than the inactivated pathogens segment during the forecast period. This growth can be attributed to the increasing demand for advanced diagnostic tests that use purified pathogen antigens. The bacterial and viral antigens market is also segmented by application into hospitals and clinics, diagnostic laboratories, academic and research institutes, vaccine manufacturers, biotechnology companies, contract research organizations (CROs), pharmaceutical companies, blood banks/transfusion centers),and others (agriculture sector). The hospitals & clinics segment accounted for the largest share of the global bacterial & viral antigen market in 2017 owing to rising incidences of infectious diseases across all regions worldwide.
Product Definition:
Bacterial and viral antigens are substances on the surface of bacteria and viruses that provoke an immune response. Antigens are important because they are the targets of immunity.
Inactivated Pathogen:
Inactivated pathogens are materials that have been inactivated or rendered inoperative for pathogenic purposes. They do not reproduce on exposure to the normal temperature and environment of a patient, and hence cannot cause disease.
Purified Pathogen:
A purified pathogen is a virus or bacteria that has been grown in the laboratory under conditions that eliminate all other possible proteins. These are used as an antigen for the production of antibodies and as vaccine material. Purified pathogens can be administered to immunized persons who have lost their immunity due to disease, accident, or any other cause.
Application Insights:
The global market is segmented by application into hospitals and clinics, diagnostic laboratories, academic and research institutes. Hospitals and clinics held the largest share in 2017 owing to the rising number of patients with acute respiratory diseases such as asthma. This segment is also anticipated to witness lucrative growth over the forecast period due to increasing investments in R&D for developing vaccines against bacterial and viral pathogens that cause respiratory diseases.
Academic & research institutes are expected to grow at a rapid pace over the forecast period due largely to increased government funding for vaccine development against a wide range of infectious diseases including influenza A (H1N1), hepatitis A, B C D viruses, adenovirus E G H K L M N P Q R S T W Y ZABV strains etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of international travelers, increasing prevalence of infectious diseases, and rising demand for vaccines. The U.S., which is at the forefront, accounted for over 70% share in North America owing to high acceptance and implementation of technologically advanced products coupled with a strong healthcare infrastructure.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare facilities due to increased government spending on this sector and growing awareness among people about vaccination programs especially after recent COVID-19 cases in countries like India, China, Japan etc.; hence boosting product demand across this region is anticipated.
Growth Factors:
- Increasing incidence of infectious diseases: The global bacterial and viral antigens market is majorly driven by the increasing incidence of infectious diseases. According to the World Health Organization, every year around 1 million people die from tuberculosis, and 2-3 million deaths are caused by malaria. In addition, there are also millions of cases of other communicable diseases such as dengue fever, cholera, and meningitis that occur each year. This is expected to drive the demand for bacterial and viral antigens in the coming years.
- Growing awareness about preventive measures: There has been a growing awareness among people about preventive measures against infectious diseases in recent years. This has led to an increase in demand for products such as vaccines and diagnostic kits that can help prevent these infections from spreading further. This is expected to drive growth in the global bacterial and viral antigens market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacterial and Viral Antigens Market Research Report
By Type
Inactivated Pathogen, Purified Pathogen
By Application
Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes
By Companies
The Native Antigen Company, Creative Diagnostics, Microbix Biosystems, SERION Immunologics, Bio-Rad Laboratories, Enzo Life Sciences, Jena Bioscience GmbH, QED Bioscience, Ross Southern Laboratories, AROTEC Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Bacterial and Viral Antigens Market Report Segments:
The global Bacterial and Viral Antigens market is segmented on the basis of:
Types
Inactivated Pathogen, Purified Pathogen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- The Native Antigen Company
- Creative Diagnostics
- Microbix Biosystems
- SERION Immunologics
- Bio-Rad Laboratories
- Enzo Life Sciences
- Jena Bioscience GmbH
- QED Bioscience
- Ross Southern Laboratories
- AROTEC Diagnostics
Highlights of The Bacterial and Viral Antigens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inactivated Pathogen
- Purified Pathogen
- By Application:
- Hospitals and Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacterial and Viral Antigens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacterial and viral antigens are proteins that are found on the surface of bacteria or viruses. These antigens help the immune system to identify and attack these organisms.
Some of the major companies in the bacterial and viral antigens market are The Native Antigen Company, Creative Diagnostics, Microbix Biosystems, SERION Immunologics, Bio-Rad Laboratories, Enzo Life Sciences, Jena Bioscience GmbH, QED Bioscience, Ross Southern Laboratories, AROTEC Diagnostics.
The bacterial and viral antigens market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacterial and Viral Antigens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bacterial and Viral Antigens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bacterial and Viral Antigens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bacterial and Viral Antigens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bacterial and Viral Antigens Market Size & Forecast, 2018-2028
4.5.1 Bacterial and Viral Antigens Market Size and Y-o-Y Growth
4.5.2 Bacterial and Viral Antigens Market Absolute $ Opportunity
Chapter 5 Global Bacterial and Viral Antigens Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bacterial and Viral Antigens Market Size Forecast by Type
5.2.1 Inactivated Pathogen
5.2.2 Purified Pathogen
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bacterial and Viral Antigens Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bacterial and Viral Antigens Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Diagnostic Laboratories
6.2.3 Academic and Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacterial and Viral Antigens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacterial and Viral Antigens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bacterial and Viral Antigens Analysis and Forecast
9.1 Introduction
9.2 North America Bacterial and Viral Antigens Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bacterial and Viral Antigens Market Size Forecast by Type
9.6.1 Inactivated Pathogen
9.6.2 Purified Pathogen
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bacterial and Viral Antigens Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Diagnostic Laboratories
9.10.3 Academic and Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bacterial and Viral Antigens Analysis and Forecast
10.1 Introduction
10.2 Europe Bacterial and Viral Antigens Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bacterial and Viral Antigens Market Size Forecast by Type
10.6.1 Inactivated Pathogen
10.6.2 Purified Pathogen
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bacterial and Viral Antigens Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Diagnostic Laboratories
10.10.3 Academic and Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bacterial and Viral Antigens Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bacterial and Viral Antigens Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bacterial and Viral Antigens Market Size Forecast by Type
11.6.1 Inactivated Pathogen
11.6.2 Purified Pathogen
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bacterial and Viral Antigens Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Diagnostic Laboratories
11.10.3 Academic and Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bacterial and Viral Antigens Analysis and Forecast
12.1 Introduction
12.2 Latin America Bacterial and Viral Antigens Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bacterial and Viral Antigens Market Size Forecast by Type
12.6.1 Inactivated Pathogen
12.6.2 Purified Pathogen
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bacterial and Viral Antigens Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Diagnostic Laboratories
12.10.3 Academic and Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bacterial and Viral Antigens Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bacterial and Viral Antigens Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bacterial and Viral Antigens Market Size Forecast by Type
13.6.1 Inactivated Pathogen
13.6.2 Purified Pathogen
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bacterial and Viral Antigens Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Diagnostic Laboratories
13.10.3 Academic and Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacterial and Viral Antigens Market: Competitive Dashboard
14.2 Global Bacterial and Viral Antigens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 The Native Antigen Company
14.3.2 Creative Diagnostics
14.3.3 Microbix Biosystems
14.3.4 SERION Immunologics
14.3.5 Bio-Rad Laboratories
14.3.6 Enzo Life Sciences
14.3.7 Jena Bioscience GmbH
14.3.8 QED Bioscience
14.3.9 Ross Southern Laboratories
14.3.10 AROTEC Diagnostics
